masthead-publications

2020

HTG EdgeSeq technology offers a competitive alternative to RNA-Seq with equivalent performance and distinct advantages.

Read how the HTG EdgeSeq technology is a competitive alternative to RNA-Seq

Download pdf 1.7MB

2018

Detecting clinically relevant ALK rearrangements: Comparing the HTG EdgeSeq ALKPlus Assay EU (CE-IVD)to a commercially available ALK FISH assay

Numerous mutations have been shown to drive oncogenesis in non-small cell lung cancer (NSCLC). Measuring these events with conventional methods is difficult given the small amount of material typically collected in the standard needle core biopsy or similar tissue collection method.

Download pdf 735KB

2017

Complement IHC Studies with the HTG EdgeSeq PATH Assay

HTG white paper: Complement IHC Studies with the HTG EdgeSeq PATH Assay. 2017

Page last updated September 21, 2020